Toll Free: 1-888-928-9744
Published: Feb, 2018 | Pages:
129 | Publisher: QYResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
In this report, the Asia-Pacific Prostate Cancer Drugs market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report split Asia-Pacific into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Prostate Cancer Drugs for these regions, from 2013 to 2025 (forecast), including China Japan South Korea Taiwan India Southeast Asia Australia Asia-Pacific Prostate Cancer Drugs market competition by top manufacturers/players, with Prostate Cancer Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including AbbVie Astellas Pharma Astra Zeneca Johnson & Johnson Sanofi GlaxoSmithKline Merck Group Novartis Amgen Bayer HealthCare Ferring Pharmaceutical Janssen Pharmaceuticals Endo Pharmaceuticals BMS Takeda Pharmaceuticals Northwest Biotherapeutics Teva Pharmaceutical Boehringer Ingelheim Foresee Pharmaceuticals Tokai Pharmaceuticals Spectrum Pharmaceuticals On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into Hormonal Therapy Chemotherapy Immunotherapy Targeted Therapy On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including Clinics Hospitals Other If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents Asia-Pacific Prostate Cancer Drugs Market Report 2018 1 Prostate Cancer Drugs Overview 1.1 Product Overview and Scope of Prostate Cancer Drugs 1.2 Classification of Prostate Cancer Drugs by Product Category 1.2.1 Asia-Pacific Prostate Cancer Drugs Market Size (Sales) Comparison by Types (2013-2025) 1.2.2 Asia-Pacific Prostate Cancer Drugs Market Size (Sales) Market Share by Type (Product Category) in 2017 1.2.3 Hormonal Therapy 1.2.4 Chemotherapy 1.2.5 Immunotherapy 1.2.6 Targeted Therapy 1.3 Asia-Pacific Prostate Cancer Drugs Market by Application/End Users 1.3.1 Asia-Pacific Prostate Cancer Drugs Sales (Volume) and Market Share Comparison by Applications (2013-2025) 1.3.2 Clinics 1.3.3 Hospitals 1.3.4 Other 1.4 Asia-Pacific Prostate Cancer Drugs Market by Region 1.4.1 Asia-Pacific Prostate Cancer Drugs Market Size (Value) Comparison by Region (2013-2025) 1.4.2 China Status and Prospect (2013-2025) 1.4.3 Japan Status and Prospect (2013-2025) 1.4.4 South Korea Status and Prospect (2013-2025) 1.4.5 Taiwan Status and Prospect (2013-2025) 1.4.6 India Status and Prospect (2013-2025) 1.4.7 Southeast Asia Status and Prospect (2013-2025) 1.4.8 Australia Status and Prospect (2013-2025) 1.5 Asia-Pacific Market Size (Value and Volume) of Prostate Cancer Drugs (2013-2025) 1.5.1 Asia-Pacific Prostate Cancer Drugs Sales and Growth Rate (2013-2025) 1.5.2 Asia-Pacific Prostate Cancer Drugs Revenue and Growth Rate (2013-2025) 2 Asia-Pacific Prostate Cancer Drugs Competition by Players/Suppliers, Region, Type and Application 2.1 Asia-Pacific Prostate Cancer Drugs Market Competition by Players/Suppliers 2.1.1 Asia-Pacific Prostate Cancer Drugs Sales Volume and Market Share of Key Players/Suppliers (2013-2018) 2.1.2 Asia-Pacific Prostate Cancer Drugs Revenue and Share by Players/Suppliers (2013-2018) 2.2 Asia-Pacific Prostate Cancer Drugs (Volume and Value) by Type 2.2.1 Asia-Pacific Prostate Cancer Drugs Sales and Market Share by Type (2013-2018) 2.2.2 Asia-Pacific Prostate Cancer Drugs Revenue and Market Share by Type (2013-2018) 2.3 Asia-Pacific Prostate Cancer Drugs (Volume) by Application 2.4 Asia-Pacific Prostate Cancer Drugs (Volume and Value) by Region 2.4.1 Asia-Pacific Prostate Cancer Drugs Sales and Market Share by Region (2013-2018) 2.4.2 Asia-Pacific Prostate Cancer Drugs Revenue and Market Share by Region (2013-2018) 3 China Prostate Cancer Drugs (Volume, Value and Sales Price) 3.1 China Prostate Cancer Drugs Sales and Value (2013-2018) 3.1.1 China Prostate Cancer Drugs Sales Volume and Growth Rate (2013-2018) 3.1.2 China Prostate Cancer Drugs Revenue and Growth Rate (2013-2018) 3.1.3 China Prostate Cancer Drugs Sales Price Trend (2013-2018) 3.2 China Prostate Cancer Drugs Sales Volume and Market Share by Type 3.3 China Prostate Cancer Drugs Sales Volume and Market Share by Application 4 Japan Prostate Cancer Drugs (Volume, Value and Sales Price) 4.1 Japan Prostate Cancer Drugs Sales and Value (2013-2018) 4.1.1 Japan Prostate Cancer Drugs Sales Volume and Growth Rate (2013-2018) 4.1.2 Japan Prostate Cancer Drugs Revenue and Growth Rate (2013-2018) 4.1.3 Japan Prostate Cancer Drugs Sales Price Trend (2013-2018) 4.2 Japan Prostate Cancer Drugs Sales Volume and Market Share by Type 4.3 Japan Prostate Cancer Drugs Sales Volume and Market Share by Application 5 South Korea Prostate Cancer Drugs (Volume, Value and Sales Price) 5.1 South Korea Prostate Cancer Drugs Sales and Value (2013-2018) 5.1.1 South Korea Prostate Cancer Drugs Sales Volume and Growth Rate (2013-2018) 5.1.2 South Korea Prostate Cancer Drugs Revenue and Growth Rate (2013-2018) 5.1.3 South Korea Prostate Cancer Drugs Sales Price Trend (2013-2018) 5.2 South Korea Prostate Cancer Drugs Sales Volume and Market Share by Type 5.3 South Korea Prostate Cancer Drugs Sales Volume and Market Share by Application 6 Taiwan Prostate Cancer Drugs (Volume, Value and Sales Price) 6.1 Taiwan Prostate Cancer Drugs Sales and Value (2013-2018) 6.1.1 Taiwan Prostate Cancer Drugs Sales Volume and Growth Rate (2013-2018) 6.1.2 Taiwan Prostate Cancer Drugs Revenue and Growth Rate (2013-2018) 6.1.3 Taiwan Prostate Cancer Drugs Sales Price Trend (2013-2018) 6.2 Taiwan Prostate Cancer Drugs Sales Volume and Market Share by Type 6.3 Taiwan Prostate Cancer Drugs Sales Volume and Market Share by Application 7 India Prostate Cancer Drugs (Volume, Value and Sales Price) 7.1 India Prostate Cancer Drugs Sales and Value (2013-2018) 7.1.1 India Prostate Cancer Drugs Sales Volume and Growth Rate (2013-2018) 7.1.2 India Prostate Cancer Drugs Revenue and Growth Rate (2013-2018) 7.1.3 India Prostate Cancer Drugs Sales Price Trend (2013-2018) 7.2 India Prostate Cancer Drugs Sales Volume and Market Share by Type 7.3 India Prostate Cancer Drugs Sales Volume and Market Share by Application 8 Southeast Asia Prostate Cancer Drugs (Volume, Value and Sales Price) 8.1 Southeast Asia Prostate Cancer Drugs Sales and Value (2013-2018) 8.1.1 Southeast Asia Prostate Cancer Drugs Sales Volume and Growth Rate (2013-2018) 8.1.2 Southeast Asia Prostate Cancer Drugs Revenue and Growth Rate (2013-2018) 8.1.3 Southeast Asia Prostate Cancer Drugs Sales Price Trend (2013-2018) 8.2 Southeast Asia Prostate Cancer Drugs Sales Volume and Market Share by Type 8.3 Southeast Asia Prostate Cancer Drugs Sales Volume and Market Share by Application 9 Australia Prostate Cancer Drugs (Volume, Value and Sales Price) 9.1 Australia Prostate Cancer Drugs Sales and Value (2013-2018) 9.1.1 Australia Prostate Cancer Drugs Sales Volume and Growth Rate (2013-2018) 9.1.2 Australia Prostate Cancer Drugs Revenue and Growth Rate (2013-2018) 9.1.3 Australia Prostate Cancer Drugs Sales Price Trend (2013-2018) 9.2 Australia Prostate Cancer Drugs Sales Volume and Market Share by Type 9.3 Australia Prostate Cancer Drugs Sales Volume and Market Share by Application 10 Asia-Pacific Prostate Cancer Drugs Players/Suppliers Profiles and Sales Data 10.1 AbbVie 10.1.1 Company Basic Information, Manufacturing Base and Competitors 10.1.2 Prostate Cancer Drugs Product Category, Application and Specification 10.1.2.1 Product A 10.1.2.2 Product B 10.1.3 AbbVie Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2013-2018) 10.1.4 Main Business/Business Overview 10.2 Astellas Pharma 10.2.1 Company Basic Information, Manufacturing Base and Competitors 10.2.2 Prostate Cancer Drugs Product Category, Application and Specification 10.2.2.1 Product A 10.2.2.2 Product B 10.2.3 Astellas Pharma Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2013-2018) 10.2.4 Main Business/Business Overview 10.3 Astra Zeneca 10.3.1 Company Basic Information, Manufacturing Base and Competitors 10.3.2 Prostate Cancer Drugs Product Category, Application and Specification 10.3.2.1 Product A 10.3.2.2 Product B 10.3.3 Astra Zeneca Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2013-2018) 10.3.4 Main Business/Business Overview 10.4 Johnson & Johnson 10.4.1 Company Basic Information, Manufacturing Base and Competitors 10.4.2 Prostate Cancer Drugs Product Category, Application and Specification 10.4.2.1 Product A 10.4.2.2 Product B 10.4.3 Johnson & Johnson Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2013-2018) 10.4.4 Main Business/Business Overview 10.5 Sanofi 10.5.1 Company Basic Information, Manufacturing Base and Competitors 10.5.2 Prostate Cancer Drugs Product Category, Application and Specification 10.5.2.1 Product A 10.5.2.2 Product B 10.5.3 Sanofi Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2013-2018) 10.5.4 Main Business/Business Overview 10.6 GlaxoSmithKline 10.6.1 Company Basic Information, Manufacturing Base and Competitors 10.6.2 Prostate Cancer Drugs Product Category, Application and Specification 10.6.2.1 Product A 10.6.2.2 Product B 10.6.3 GlaxoSmithKline Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2013-2018) 10.6.4 Main Business/Business Overview 10.7 Merck Group 10.7.1 Company Basic Information, Manufacturing Base and Competitors 10.7.2 Prostate Cancer Drugs Product Category, Application and Specification 10.7.2.1 Product A 10.7.2.2 Product B 10.7.3 Merck Group Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2013-2018) 10.7.4 Main Business/Business Overview 10.8 Novartis 10.8.1 Company Basic Information, Manufacturing Base and Competitors 10.8.2 Prostate Cancer Drugs Product Category, Application and Specification 10.8.2.1 Product A 10.8.2.2 Product B 10.8.3 Novartis Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2013-2018) 10.8.4 Main Business/Business Overview 10.9 Amgen 10.9.1 Company Basic Information, Manufacturing Base and Competitors 10.9.2 Prostate Cancer Drugs Product Category, Application and Specification 10.9.2.1 Product A 10.9.2.2 Product B 10.9.3 Amgen Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2013-2018) 10.9.4 Main Business/Business Overview 10.10 Bayer HealthCare 10.10.1 Company Basic Information, Manufacturing Base and Competitors 10.10.2 Prostate Cancer Drugs Product Category, Application and Specification 10.10.2.1 Product A 10.10.2.2 Product B 10.10.3 Bayer HealthCare Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2013-2018) 10.10.4 Main Business/Business Overview 10.11 Ferring Pharmaceutical 10.12 Janssen Pharmaceuticals 10.13 Endo Pharmaceuticals 10.14 BMS 10.15 Takeda Pharmaceuticals 10.16 Northwest Biotherapeutics 10.17 Teva Pharmaceutical 10.18 Boehringer Ingelheim 10.19 Foresee Pharmaceuticals 10.20 Tokai Pharmaceuticals 10.21 Spectrum Pharmaceuticals 11 Prostate Cancer Drugs Manufacturing Cost Analysis 11.1 Prostate Cancer Drugs Key Raw Materials Analysis 11.1.1 Key Raw Materials 11.1.2 Price Trend of Key Raw Materials 11.1.3 Key Suppliers of Raw Materials 11.1.4 Market Concentration Rate of Raw Materials 11.2 Proportion of Manufacturing Cost Structure 11.2.1 Raw Materials 11.2.2 Labor Cost 11.2.3 Manufacturing Expenses 11.3 Manufacturing Process Analysis of Prostate Cancer Drugs 12 Industrial Chain, Sourcing Strategy and Downstream Buyers 12.1 Prostate Cancer Drugs Industrial Chain Analysis 12.2 Upstream Raw Materials Sourcing 12.3 Raw Materials Sources of Prostate Cancer Drugs Major Manufacturers in 2017 12.4 Downstream Buyers 13 Marketing Strategy Analysis, Distributors/Traders 13.1 Marketing Channel 13.1.1 Direct Marketing 13.1.2 Indirect Marketing 13.1.3 Marketing Channel Development Trend 13.2 Market Positioning 13.2.1 Pricing Strategy 13.2.2 Brand Strategy 13.2.3 Target Client 13.3 Distributors/Traders List 14 Market Effect Factors Analysis 14.1 Technology Progress/Risk 14.1.1 Substitutes Threat 14.1.2 Technology Progress in Related Industry 14.2 Consumer Needs/Customer Preference Change 14.3 Economic/Political Environmental Change 15 Asia-Pacific Prostate Cancer Drugs Market Forecast (2018-2025) 15.1 Asia-Pacific Prostate Cancer Drugs Sales Volume, Revenue and Price Forecast (2018-2025) 15.1.1 Asia-Pacific Prostate Cancer Drugs Sales Volume and Growth Rate Forecast (2018-2025) 15.1.2 Asia-Pacific Prostate Cancer Drugs Revenue and Growth Rate Forecast (2018-2025) 15.1.3 Asia-Pacific Prostate Cancer Drugs Price and Trend Forecast (2018-2025) 15.2 Asia-Pacific Prostate Cancer Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025) 15.2.1 Asia-Pacific Prostate Cancer Drugs Sales Volume and Growth Rate Forecast by Region (2018-2025) 15.2.2 Asia-Pacific Prostate Cancer Drugs Revenue and Growth Rate Forecast by Region (2018-2025) 15.2.3 China Prostate Cancer Drugs Sales, Revenue and Growth Rate Forecast (2018-2025) 15.2.4 Japan Prostate Cancer Drugs Sales, Revenue and Growth Rate Forecast (2018-2025) 15.2.5 South Korea Prostate Cancer Drugs Sales, Revenue and Growth Rate Forecast (2018-2025) 15.2.6 Taiwan Prostate Cancer Drugs Sales, Revenue and Growth Rate Forecast (2018-2025) 15.2.7 India Prostate Cancer Drugs Sales, Revenue and Growth Rate Forecast (2018-2025) 15.2.8 Southeast Asia Prostate Cancer Drugs Sales, Revenue and Growth Rate Forecast (2018-2025) 15.2.9 Australia Prostate Cancer Drugs Sales, Revenue and Growth Rate Forecast (2018-2025) 15.3 Asia-Pacific Prostate Cancer Drugs Sales, Revenue and Price Forecast by Type (2018-2025) 15.3.1 Asia-Pacific Prostate Cancer Drugs Sales Forecast by Type (2018-2025) 15.3.2 Asia-Pacific Prostate Cancer Drugs Revenue Forecast by Type (2018-2025) 15.3.3 Asia-Pacific Prostate Cancer Drugs Price Forecast by Type (2018-2025) 15.4 Asia-Pacific Prostate Cancer Drugs Sales Forecast by Application (2018-2025) 16 Research Findings and Conclusion 17 Appendix 17.1 Methodology/Research Approach 17.1.1 Research Programs/Design 17.1.2 Market Size Estimation 17.1.3 Market Breakdown and Data Triangulation 17.2 Data Source 17.2.1 Secondary Sources 17.2.2 Primary Sources 17.3 Disclaimer
List of Tables and Figures Figure Product Picture of Prostate Cancer Drugs Figure Asia-Pacific Prostate Cancer Drugs Sales Volume (K Pcs) by Type (2013-2025) Figure Asia-Pacific Prostate Cancer Drugs Sales Volume Market Share by Type (Product Category) in 2017 Figure Hormonal Therapy Product Picture Figure Chemotherapy Product Picture Figure Immunotherapy Product Picture Figure Targeted Therapy Product Picture Figure Asia-Pacific Prostate Cancer Drugs Sales (K Pcs) by Application (2013-2025) Figure Asia-Pacific Sales Market Share of Prostate Cancer Drugs by Application in 2017 Figure Clinics Examples Table Key Downstream Customer in Clinics Figure Hospitals Examples Table Key Downstream Customer in Hospitals Figure Other Examples Table Key Downstream Customer in Other Figure Asia-Pacific Prostate Cancer Drugs Market Size (Million USD) by Region (2013-2025) Figure China Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2013-2025) Figure Japan Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2013-2025) Figure South Korea Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2013-2025) Figure Taiwan Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2013-2025) Figure India Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2013-2025) Figure Southeast Asia Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2013-2025) Figure Australia Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2013-2025) Figure Asia-Pacific Prostate Cancer Drugs Sales Volume (K Pcs) and Growth Rate (2013-2025) Figure Asia-Pacific Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2013-2025) Figure Asia-Pacific Prostate Cancer Drugs Market Major Players Product Sales Volume (K Pcs)(2013-2018) Table Asia-Pacific Prostate Cancer Drugs Sales (K Pcs) of Key Players/Suppliers (2013-2018) Table Asia-Pacific Prostate Cancer Drugs Sales Share by Players/Suppliers (2013-2018) Figure 2017 Asia-Pacific Prostate Cancer Drugs Sales Share by Players/Suppliers Figure 2017 Asia-Pacific Prostate Cancer Drugs Sales Share by Players/Suppliers Figure Asia-Pacific Prostate Cancer Drugs Market Major Players Product Revenue (Million USD) 2013-2018 Table Asia-Pacific Prostate Cancer Drugs Revenue (Million USD) by Players/Suppliers (2013-2018) Table Asia-Pacific Prostate Cancer Drugs Revenue Share by Players/Suppliers (2013-2018) Figure 2017 Asia-Pacific Prostate Cancer Drugs Revenue Share by Players Figure 2017 Asia-Pacific Prostate Cancer Drugs Revenue Share by Players Table Asia-Pacific Prostate Cancer Drugs Sales and Market Share by Type (2013-2018) Table Asia-Pacific Prostate Cancer Drugs Sales Share by Type (2013-2018) Figure Sales Market Share of Prostate Cancer Drugs by Type (2013-2018) Figure Asia-Pacific Prostate Cancer Drugs Sales Growth Rate by Type (2013-2018) Table Asia-Pacific Prostate Cancer Drugs Revenue (Million USD) and Market Share by Type (2013-2018) Table Asia-Pacific Prostate Cancer Drugs Revenue Share by Type (2013-2018) Figure Revenue Market Share of Prostate Cancer Drugs by Type (2013-2018) Figure Asia-Pacific Prostate Cancer Drugs Revenue Growth Rate by Type (2013-2018) Table Asia-Pacific Prostate Cancer Drugs Sales Volume (K Pcs) and Market Share by Region (2013-2018) Table Asia-Pacific Prostate Cancer Drugs Sales Share by Region (2013-2018) Figure Sales Market Share of Prostate Cancer Drugs by Region (2013-2018) Figure Asia-Pacific Prostate Cancer Drugs Sales Market Share by Region in 2017 Table Asia-Pacific Prostate Cancer Drugs Revenue (Million USD) and Market Share by Region (2013-2018) Table Asia-Pacific Prostate Cancer Drugs Revenue Share (%) by Region (2013-2018) Figure Revenue Market Share of Prostate Cancer Drugs by Region (2013-2018) Figure Asia-Pacific Prostate Cancer Drugs Revenue Market Share by Region in 2017 Table Asia-Pacific Prostate Cancer Drugs Sales Volume (K Pcs) and Market Share by Application (2013-2018) Table Asia-Pacific Prostate Cancer Drugs Sales Share (%) by Application (2013-2018) Figure Asia-Pacific Prostate Cancer Drugs Sales Market Share by Application (2013-2018) Figure Asia-Pacific Prostate Cancer Drugs Sales Market Share by Application (2013-2018) Figure China Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2013-2018) Figure China Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2013-2018) Figure China Prostate Cancer Drugs Sales Price (USD/Pcs) Trend (2013-2018) Table China Prostate Cancer Drugs Sales Volume (K Pcs) by Type (2013-2018) Table China Prostate Cancer Drugs Sales Volume Market Share by Type (2013-2018) Figure China Prostate Cancer Drugs Sales Volume Market Share by Type in 2017 Table China Prostate Cancer Drugs Sales Volume (K Pcs) by Applications (2013-2018) Table China Prostate Cancer Drugs Sales Volume Market Share by Application (2013-2018) Figure China Prostate Cancer Drugs Sales Volume Market Share by Application in 2017 Figure Japan Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2013-2018) Figure Japan Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2013-2018) Figure Japan Prostate Cancer Drugs Sales Price (USD/Pcs) Trend (2013-2018) Table Japan Prostate Cancer Drugs Sales Volume (K Pcs) by Type (2013-2018) Table Japan Prostate Cancer Drugs Sales Volume Market Share by Type (2013-2018) Figure Japan Prostate Cancer Drugs Sales Volume Market Share by Type in 2017 Table Japan Prostate Cancer Drugs Sales Volume (K Pcs) by Applications (2013-2018) Table Japan Prostate Cancer Drugs Sales Volume Market Share by Application (2013-2018) Figure Japan Prostate Cancer Drugs Sales Volume Market Share by Application in 2017 Figure South Korea Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2013-2018) Figure South Korea Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2013-2018) Figure South Korea Prostate Cancer Drugs Sales Price (USD/Pcs) Trend (2013-2018) Table South Korea Prostate Cancer Drugs Sales Volume (K Pcs) by Type (2013-2018) Table South Korea Prostate Cancer Drugs Sales Volume Market Share by Type (2013-2018) Figure South Korea Prostate Cancer Drugs Sales Volume Market Share by Type in 2017 Table South Korea Prostate Cancer Drugs Sales Volume (K Pcs) by Applications (2013-2018) Table South Korea Prostate Cancer Drugs Sales Volume Market Share by Application (2013-2018) Figure South Korea Prostate Cancer Drugs Sales Volume Market Share by Application in 2017 Figure Taiwan Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2013-2018) Figure Taiwan Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2013-2018) Figure Taiwan Prostate Cancer Drugs Sales Price (USD/Pcs) Trend (2013-2018) Table Taiwan Prostate Cancer Drugs Sales Volume (K Pcs) by Type (2013-2018) Table Taiwan Prostate Cancer Drugs Sales Volume Market Share by Type (2013-2018) Figure Taiwan Prostate Cancer Drugs Sales Volume Market Share by Type in 2017 Table Taiwan Prostate Cancer Drugs Sales Volume (K Pcs) by Applications (2013-2018) Table Taiwan Prostate Cancer Drugs Sales Volume Market Share by Application (2013-2018) Figure Taiwan Prostate Cancer Drugs Sales Volume Market Share by Application in 2017 Figure India Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2013-2018) Figure India Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2013-2018) Figure India Prostate Cancer Drugs Sales Price (USD/Pcs) Trend (2013-2018) Table India Prostate Cancer Drugs Sales Volume (K Pcs) by Type (2013-2018) Table India Prostate Cancer Drugs Sales Volume Market Share by Type (2013-2018) Figure India Prostate Cancer Drugs Sales Volume Market Share by Type in 2017 Table India Prostate Cancer Drugs Sales Volume (K Pcs) by Application (2013-2018) Table India Prostate Cancer Drugs Sales Volume Market Share by Application (2013-2018) Figure India Prostate Cancer Drugs Sales Volume Market Share by Application in 2017 Figure Southeast Asia Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2013-2018) Figure Southeast Asia Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2013-2018) Figure Southeast Asia Prostate Cancer Drugs Sales Price (USD/Pcs) Trend (2013-2018) Table Southeast Asia Prostate Cancer Drugs Sales Volume (K Pcs) by Type (2013-2018) Table Southeast Asia Prostate Cancer Drugs Sales Volume Market Share by Type (2013-2018) Figure Southeast Asia Prostate Cancer Drugs Sales Volume Market Share by Type in 2017 Table Southeast Asia Prostate Cancer Drugs Sales Volume (K Pcs) by Applications (2013-2018) Table Southeast Asia Prostate Cancer Drugs Sales Volume Market Share by Application (2013-2018) Figure Southeast Asia Prostate Cancer Drugs Sales Volume Market Share by Application in 2017 Figure Australia Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2013-2018) Figure Australia Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2013-2018) Figure Australia Prostate Cancer Drugs Sales Price (USD/Pcs) Trend (2013-2018) Table Australia Prostate Cancer Drugs Sales Volume (K Pcs) by Type (2013-2018) Table Australia Prostate Cancer Drugs Sales Volume Market Share by Type (2013-2018) Figure Australia Prostate Cancer Drugs Sales Volume Market Share by Type in 2017 Table Australia Prostate Cancer Drugs Sales Volume (K Pcs) by Applications (2013-2018) Table Australia Prostate Cancer Drugs Sales Volume Market Share by Application (2013-2018) Figure Australia Prostate Cancer Drugs Sales Volume Market Share by Application in 2017 Table AbbVie Prostate Cancer Drugs Basic Information List Table AbbVie Prostate Cancer Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure AbbVie Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2013-2018) Figure AbbVie Prostate Cancer Drugs Sales Market Share in Asia-Pacific (2013-2018) Figure AbbVie Prostate Cancer Drugs Revenue Market Share in Asia-Pacific (2013-2018) Table Astellas Pharma Prostate Cancer Drugs Basic Information List Table Astellas Pharma Prostate Cancer Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure Astellas Pharma Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2013-2018) Figure Astellas Pharma Prostate Cancer Drugs Sales Market Share in Asia-Pacific (2013-2018) Figure Astellas Pharma Prostate Cancer Drugs Revenue Market Share in Asia-Pacific (2013-2018) Table Astra Zeneca Prostate Cancer Drugs Basic Information List Table Astra Zeneca Prostate Cancer Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure Astra Zeneca Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2013-2018) Figure Astra Zeneca Prostate Cancer Drugs Sales Market Share in Asia-Pacific (2013-2018) Figure Astra Zeneca Prostate Cancer Drugs Revenue Market Share in Asia-Pacific (2013-2018) Table Johnson & Johnson Prostate Cancer Drugs Basic Information List Table Johnson & Johnson Prostate Cancer Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure Johnson & Johnson Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2013-2018) Figure Johnson & Johnson Prostate Cancer Drugs Sales Market Share in Asia-Pacific (2013-2018) Figure Johnson & Johnson Prostate Cancer Drugs Revenue Market Share in Asia-Pacific (2013-2018) Table Sanofi Prostate Cancer Drugs Basic Information List Table Sanofi Prostate Cancer Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure Sanofi Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2013-2018) Figure Sanofi Prostate Cancer Drugs Sales Market Share in Asia-Pacific (2013-2018) Figure Sanofi Prostate Cancer Drugs Revenue Market Share in Asia-Pacific (2013-2018) Table GlaxoSmithKline Prostate Cancer Drugs Basic Information List Table GlaxoSmithKline Prostate Cancer Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure GlaxoSmithKline Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2013-2018) Figure GlaxoSmithKline Prostate Cancer Drugs Sales Market Share in Asia-Pacific (2013-2018) Figure GlaxoSmithKline Prostate Cancer Drugs Revenue Market Share in Asia-Pacific (2013-2018) Table Merck Group Prostate Cancer Drugs Basic Information List Table Merck Group Prostate Cancer Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure Merck Group Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2013-2018) Figure Merck Group Prostate Cancer Drugs Sales Market Share in Asia-Pacific (2013-2018) Figure Merck Group Prostate Cancer Drugs Revenue Market Share in Asia-Pacific (2013-2018) Table Novartis Prostate Cancer Drugs Basic Information List Table Novartis Prostate Cancer Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure Novartis Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2013-2018) Figure Novartis Prostate Cancer Drugs Sales Market Share in Asia-Pacific (2013-2018) Figure Novartis Prostate Cancer Drugs Revenue Market Share in Asia-Pacific (2013-2018) Table Amgen Prostate Cancer Drugs Basic Information List Table Amgen Prostate Cancer Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure Amgen Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2013-2018) Figure Amgen Prostate Cancer Drugs Sales Market Share in Asia-Pacific (2013-2018) Figure Amgen Prostate Cancer Drugs Revenue Market Share in Asia-Pacific (2013-2018) Table Bayer HealthCare Prostate Cancer Drugs Basic Information List Table Bayer HealthCare Prostate Cancer Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure Bayer HealthCare Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2013-2018) Figure Bayer HealthCare Prostate Cancer Drugs Sales Market Share in Asia-Pacific (2013-2018) Figure Bayer HealthCare Prostate Cancer Drugs Revenue Market Share in Asia-Pacific (2013-2018) Table Ferring Pharmaceutical Prostate Cancer Drugs Basic Information List Table Janssen Pharmaceuticals Prostate Cancer Drugs Basic Information List Table Endo Pharmaceuticals Prostate Cancer Drugs Basic Information List Table BMS Prostate Cancer Drugs Basic Information List Table Takeda Pharmaceuticals Prostate Cancer Drugs Basic Information List Table Northwest Biotherapeutics Prostate Cancer Drugs Basic Information List Table Teva Pharmaceutical Prostate Cancer Drugs Basic Information List Table Boehringer Ingelheim Prostate Cancer Drugs Basic Information List Table Foresee Pharmaceuticals Prostate Cancer Drugs Basic Information List Table Tokai Pharmaceuticals Prostate Cancer Drugs Basic Information List Table Spectrum Pharmaceuticals Prostate Cancer Drugs Basic Information List Table Production Base and Market Concentration Rate of Raw Material Figure Price (USD/Pcs) Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Prostate Cancer Drugs Figure Manufacturing Process Analysis of Prostate Cancer Drugs Figure Prostate Cancer Drugs Industrial Chain Analysis Table Raw Materials Sources of Prostate Cancer Drugs Major Manufacturers in 2017 Table Major Buyers of Prostate Cancer Drugs Table Distributors/Traders List Figure Asia-Pacific Prostate Cancer Drugs Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025) Figure Asia-Pacific Prostate Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025) Figure Asia-Pacific Prostate Cancer Drugs Price (USD/Pcs) and Trend Forecast (2018-2025) Table Asia-Pacific Prostate Cancer Drugs Sales Volume (K Pcs) Forecast by Region (2018-2025) Figure Asia-Pacific Prostate Cancer Drugs Sales Volume Market Share Forecast by Region (2018-2025) Figure Asia-Pacific Prostate Cancer Drugs Sales Volume Market Share Forecast by Region in 2025 Table Asia-Pacific Prostate Cancer Drugs Revenue (Million USD) Forecast by Region (2018-2025) Figure Asia-Pacific Prostate Cancer Drugs Revenue Market Share Forecast by Region (2018-2025) Figure Asia-Pacific Prostate Cancer Drugs Revenue Market Share Forecast by Region in 2025 Figure China Prostate Cancer Drugs Sales (K Pcs) and Growth Rate Forecast (2018-2025) Figure China Prostate Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025) Figure Japan Prostate Cancer Drugs Sales (K Pcs) and Growth Rate Forecast (2018-2025) Figure Japan Prostate Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025) Figure South Korea Prostate Cancer Drugs Sales (K Pcs) and Growth Rate Forecast (2018-2025) Figure South Korea Prostate Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025) Figure Taiwan Prostate Cancer Drugs Sales (K Pcs) and Growth Rate Forecast (2018-2025) Figure Taiwan Prostate Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025) Figure India Prostate Cancer Drugs Sales (K Pcs) and Growth Rate Forecast (2018-2025) Figure India Prostate Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025) Figure Southeast Asia Prostate Cancer Drugs Sales (K Pcs) and Growth Rate Forecast (2018-2025) Figure Southeast Asia Prostate Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025) Figure Australia Prostate Cancer Drugs Sales (K Pcs) and Growth Rate Forecast (2018-2025) Figure Australia Prostate Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025) Table Asia-Pacific Prostate Cancer Drugs Sales (K Pcs) Forecast by Type (2018-2025) Figure Asia-Pacific Prostate Cancer Drugs Sales Market Share Forecast by Type (2018-2025) Table Asia-Pacific Prostate Cancer Drugs Revenue (Million USD) Forecast by Type (2018-2025) Figure Asia-Pacific Prostate Cancer Drugs Revenue Market Share Forecast by Type (2018-2025) Table Asia-Pacific Prostate Cancer Drugs Price (USD/Pcs) Forecast by Type (2018-2025) Table Asia-Pacific Prostate Cancer Drugs Sales (K Pcs) Forecast by Application (2018-2025) Figure Asia-Pacific Prostate Cancer Drugs Sales Market Share Forecast by Application (2018-2025) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.